{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "An overview of Dan Estay’s background and the journey that led him to SonoVascular\r",
      "startTime": 172,
      "endTime": 484
    },
    {
      "title": "The core idea behind SonoVascular — combining mechanical and pharmacological therapy to treat thrombosis\r",
      "startTime": 484,
      "endTime": 813
    },
    {
      "title": "Why differentiation alone isn’t enough, and how Dan evaluates market size and viability before building\r",
      "startTime": 813,
      "endTime": 1118
    },
    {
      "title": "The four risks every medtech founder should assess: technical, clinical, regulatory, and market\r",
      "startTime": 1118,
      "endTime": 1315
    },
    {
      "title": "Why Dan chose Chile for SonoVascular's FIH study and what he looks for in a clinical trial site\r",
      "startTime": 1315,
      "endTime": 1745
    },
    {
      "title": "Why Dan would rethink his use of convertible notes and approach the cap table more strategically\r",
      "startTime": 1745,
      "endTime": 2308
    },
    {
      "title": "Why grants should supplement your funding strategy, not lead it\r",
      "startTime": 2308,
      "endTime": 2566
    },
    {
      "title": "What Dan looks for when hiring for startups",
      "startTime": 2566,
      "endTime": 0
    }
  ]
}